Black CM - Search Results

1

An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis.

Denton CP, Engelhart M, Tvede N, Wilson H, Khan K, Shiwen X, Carreira PE, Diaz Gonzalez F, Black CM, van den Hoogen FH. Denton CP, et al. Among authors: black cm. Ann Rheum Dis. 2009 Sep;68(9):1433-9. doi: 10.1136/ard.2008.096123. Epub 2008 Sep 9. Ann Rheum Dis. 2009. PMID: 18782794 Clinical Trial.

2

Pulmonary hypertension in systemic sclerosis.

Denton CP, Black CM. Denton CP, et al. Among authors: black cm. Rheum Dis Clin North Am. 2003 May;29(2):335-49, vii. doi: 10.1016/s0889-857x(03)00024-3. Rheum Dis Clin North Am. 2003. PMID: 12841298 Review.

3

The myth of pulmonary Raynaud's phenomenon: the contribution of pulmonary arterial vasospasm in patients with systemic sclerosis related pulmonary arterial hypertension.

Mukerjee D, Yap LB, Ong V, Denton CP, Howells K, Black CM, Coghlan JG. Mukerjee D, et al. Among authors: black cm. Ann Rheum Dis. 2004 Dec;63(12):1627-31. doi: 10.1136/ard.2003.015289. Ann Rheum Dis. 2004. PMID: 15547087 Free PMC article.

4

Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score.

Dziadzio M, Smith RE, Abraham DJ, Black CM, Denton CP. Dziadzio M, et al. Among authors: black cm. Rheumatology (Oxford). 2005 Dec;44(12):1518-24. doi: 10.1093/rheumatology/kei088. Epub 2005 Sep 13. Rheumatology (Oxford). 2005. PMID: 16159952

5

Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.

Denton CP, Humbert M, Rubin L, Black CM. Denton CP, et al. Among authors: black cm. Ann Rheum Dis. 2006 Oct;65(10):1336-40. doi: 10.1136/ard.2005.048967. Epub 2006 Jun 22. Ann Rheum Dis. 2006. PMID: 16793845 Free PMC article. Clinical Trial.

6

Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysis.

Nihtyanova SI, Brough GM, Black CM, Denton CP. Nihtyanova SI, et al. Among authors: black cm. Rheumatology (Oxford). 2007 Mar;46(3):442-5. doi: 10.1093/rheumatology/kel244. Epub 2006 Aug 9. Rheumatology (Oxford). 2007. PMID: 16899504

7

Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?

Carulli MT, Handler C, Coghlan JG, Black CM, Denton CP. Carulli MT, et al. Among authors: black cm. Ann Rheum Dis. 2008 Jan;67(1):105-9. doi: 10.1136/ard.2006.067967. Epub 2007 Jun 29. Ann Rheum Dis. 2008. PMID: 17604287

8

Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis.

Nihtyanova SI, Brough GM, Black CM, Denton CP. Nihtyanova SI, et al. Among authors: black cm. Ann Rheum Dis. 2008 Jan;67(1):120-3. doi: 10.1136/ard.2007.072686. Epub 2007 Jul 27. Ann Rheum Dis. 2008. PMID: 17660220

9

Does long term therapy with lansoprazole slow progression of oesophageal involvement in systemic sclerosis?

Pakozdi A, Wilson H, Black CM, Denton CP. Pakozdi A, et al. Among authors: black cm. Clin Exp Rheumatol. 2009 May-Jun;27(3 Suppl 54):5-8. Clin Exp Rheumatol. 2009. PMID: 19796554 Clinical Trial.

10

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach.

Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, Black CM, Coghlan JG. Mukerjee D, et al. Among authors: black cm. Ann Rheum Dis. 2003 Nov;62(11):1088-93. doi: 10.1136/ard.62.11.1088. Ann Rheum Dis. 2003. PMID: 14583573 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

500 results

Search Page

Filters